Spectral AI will report Q2 2025 financial results on August 12, followed by a conference call at 5 PM ET.
Quiver AI Summary
Spectral AI, a Dallas-based company specializing in AI-driven medical diagnostics for wound care, announced that it will release its financial results for the second quarter of 2025 on August 12, 2025, following market close. The company will conduct a conference call at 5:00 pm Eastern Time on the same day to discuss these results, with details for participation provided. Spectral AI is focused on improving treatment decisions in wound care, particularly for burn patients, through its DeepView® System, which offers predictive assessments of wound healing potential. The system aims to enhance patient outcomes and reduce healthcare costs by providing faster and more accurate treatment insights. Investors are cautioned to consider the risks associated with forward-looking statements made in the release.
Potential Positives
- Spectral AI will report its financial results for Q2 2025 on August 12, 2025, which provides transparency and accountability to investors.
- The company is focused on revolutionizing wound care management with its AI-driven DeepView System, aiming to improve patient outcomes and reduce healthcare costs.
- The upcoming conference call allows investors to gain insights into the company's performance and future direction, fostering engagement and trust.
- The emphasis on exceeding the current standard of care indicates a commitment to innovation and quality in medical diagnostics.
Potential Negatives
- The company relies heavily on forward-looking statements, which could create uncertainty regarding its future performance and may cause investors to question its stability.
- The press release does not provide any current financial metrics or results, potentially indicating performance issues or lack of transparency.
- The emphasis on revolutionary technology may lead to high expectations that, if unmet, could result in significant reputational damage for the company.
FAQ
When will Spectral AI report its financial results?
Spectral AI will report its financial results for Q2 on August 12, 2025, after the market closes.
How can investors participate in the conference call?
Investors can participate by dialing 833-630-1956 in the U.S. or 412-317-1837 internationally.
Where can I access the webcast for the conference call?
The webcast can be accessed from the Events & Presentations section of the Investor Relations page on their website.
What is the DeepView System?
The DeepView System is an AI-driven device designed for objective assessments of burn wound healing potential.
What are the benefits of the DeepView System?
The system aims to improve patient outcomes and reduce healthcare costs by providing fast and accurate treatment insights.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MDAI Hedge Fund Activity
We have seen 12 institutional investors add shares of $MDAI stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 232,125 shares (+125.6%) to their portfolio in Q1 2025, for an estimated $266,943
- BRIDGEWAY CAPITAL MANAGEMENT, LLC added 174,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $200,099
- RENAISSANCE TECHNOLOGIES LLC removed 96,025 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $110,428
- MORGAN STANLEY removed 56,731 shares (-85.6%) from their portfolio in Q1 2025, for an estimated $65,240
- UBS GROUP AG removed 52,909 shares (-41.8%) from their portfolio in Q1 2025, for an estimated $60,845
- JANE STREET GROUP, LLC removed 32,442 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $37,308
- MILLINGTON FINANCIAL ADVISORS, LLC removed 30,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $34,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MDAI Analyst Ratings
Wall Street analysts have issued reports on $MDAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 04/02/2025
To track analyst ratings and price targets for $MDAI, check out Quiver Quantitative's $MDAI forecast page.
Full Release
DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView ® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2025 on Tuesday, August 12, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.
Investors interested in participating in the live call can dial:
- 833-630-1956 – U.S.
- 412-317-1837 – International
A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events .
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown ® ” with its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com .
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
For Media and Investor Relations, please contact :
David Kugelman
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email:
[email protected]